BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 991 filers reported holding BAXTER INTL INC in Q3 2022. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,989,000 | -75.7% | 30,952 | -70.7% | 0.04% | -70.7% |
| Q1 2022 | $8,200,000 | +15.4% | 105,742 | +27.8% | 0.12% | +35.2% |
| Q4 2021 | $7,104,000 | +3.4% | 82,752 | -3.1% | 0.09% | +1.1% |
| Q3 2021 | $6,868,000 | -6.5% | 85,381 | -6.4% | 0.09% | +7.1% |
| Q2 2021 | $7,344,000 | -64.9% | 91,217 | -63.2% | 0.08% | -65.0% |
| Q1 2021 | $20,924,000 | -19.1% | 248,071 | -23.0% | 0.24% | -18.4% |
| Q4 2020 | $25,867,000 | +0.3% | 322,351 | +0.5% | 0.29% | -4.9% |
| Q3 2020 | $25,787,000 | -6.8% | 320,648 | -0.2% | 0.31% | -5.2% |
| Q2 2020 | $27,667,000 | +16.5% | 321,319 | +9.8% | 0.33% | +3.5% |
| Q1 2020 | $23,750,000 | -3.6% | 292,509 | -0.7% | 0.32% | +25.0% |
| Q4 2019 | $24,631,000 | -53.1% | 294,546 | -51.0% | 0.25% | -52.9% |
| Q3 2019 | $52,535,000 | +3.4% | 600,594 | -3.2% | 0.54% | +0.8% |
| Q2 2019 | $50,831,000 | -1.5% | 620,636 | -2.2% | 0.53% | -5.0% |
| Q1 2019 | $51,613,000 | +23.3% | 634,759 | -0.2% | 0.56% | +1.1% |
| Q4 2018 | $41,875,000 | -24.8% | 636,193 | -11.9% | 0.55% | -15.1% |
| Q3 2018 | $55,681,000 | +6.1% | 722,269 | +1.6% | 0.65% | +0.8% |
| Q2 2018 | $52,481,000 | +16.9% | 710,723 | +3.0% | 0.65% | +12.0% |
| Q1 2018 | $44,885,000 | +1.6% | 690,095 | +0.9% | 0.58% | -1.5% |
| Q4 2017 | $44,197,000 | +8.4% | 683,715 | +5.2% | 0.59% | +7.1% |
| Q3 2017 | $40,776,000 | +6.6% | 649,793 | +2.8% | 0.55% | +1.3% |
| Q2 2017 | $38,256,000 | +108.8% | 631,892 | +78.8% | 0.54% | +103.8% |
| Q1 2017 | $18,326,000 | +19.6% | 353,354 | +2.2% | 0.26% | +22.7% |
| Q4 2016 | $15,325,000 | +13.6% | 345,596 | +22.0% | 0.22% | +7.5% |
| Q3 2016 | $13,490,000 | -4.2% | 283,376 | -9.0% | 0.20% | -13.7% |
| Q2 2016 | $14,079,000 | -1.0% | 311,318 | -10.0% | 0.23% | -17.1% |
| Q1 2016 | $14,218,000 | +251.6% | 346,083 | +226.6% | 0.28% | +212.2% |
| Q4 2015 | $4,044,000 | -34.2% | 105,970 | -43.4% | 0.09% | -40.0% |
| Q3 2015 | $6,148,000 | -61.1% | 187,136 | -17.3% | 0.15% | -59.3% |
| Q2 2015 | $15,819,000 | +1.7% | 226,193 | -0.4% | 0.37% | -0.8% |
| Q1 2015 | $15,551,000 | +6.8% | 227,002 | +14.3% | 0.37% | -7.7% |
| Q4 2014 | $14,560,000 | +19.2% | 198,650 | +16.7% | 0.40% | +6.1% |
| Q3 2014 | $12,213,000 | -48.0% | 170,161 | -47.6% | 0.38% | +2.4% |
| Q2 2014 | $23,478,000 | +70.3% | 324,716 | +73.3% | 0.37% | -20.7% |
| Q1 2014 | $13,790,000 | +39.4% | 187,411 | +31.8% | 0.47% | +36.4% |
| Q4 2013 | $9,890,000 | +35.1% | 142,186 | +27.6% | 0.34% | +31.4% |
| Q3 2013 | $7,322,000 | +4.5% | 111,455 | +10.2% | 0.26% | +0.8% |
| Q2 2013 | $7,009,000 | – | 101,170 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |